137 related articles for article (PubMed ID: 20349694)
1. Medicolegal issues arising when pacemaker and implantable cardioverter defibrillator devices are deactivated in terminally ill patients.
McGeary A; Eldergill A
Med Sci Law; 2010 Jan; 50(1):40-4. PubMed ID: 20349694
[TBL] [Abstract][Full Text] [Related]
2. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
[TBL] [Abstract][Full Text] [Related]
3. Deactivating cardiac pacemakers and implantable cardioverter defibrillators in terminally ill patients.
Beca JP; Rosselot E; Asenjo R; Anguita V; Quevedo R
Camb Q Healthc Ethics; 2009; 18(3):236-40. PubMed ID: 19460224
[No Abstract] [Full Text] [Related]
4. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
Mueller PS; Hook CC; Hayes DL
Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
[TBL] [Abstract][Full Text] [Related]
5. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.
Kapa S; Mueller PS; Hayes DL; Asirvatham SJ
Mayo Clin Proc; 2010 Nov; 85(11):981-90. PubMed ID: 20843982
[TBL] [Abstract][Full Text] [Related]
6. The law regarding assisted dying for the terminally ill in the UK.
Dimond B
Int J Palliat Nurs; 2005 Nov; 11(11):582-3; discussion 584. PubMed ID: 16471045
[TBL] [Abstract][Full Text] [Related]
7. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
Gura MT
AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
[TBL] [Abstract][Full Text] [Related]
8. [Deactivating pacemakers in terminally ill patients].
Hotvedt R
Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1680. PubMed ID: 18704136
[No Abstract] [Full Text] [Related]
9. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
[TBL] [Abstract][Full Text] [Related]
10. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
Kay GN; Bittner GT
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
[No Abstract] [Full Text] [Related]
11. Deactivating the implantable cardioverter-defibrillator: a biofixture analysis.
Paola FA; Walker RM
South Med J; 2000 Jan; 93(1):20-3. PubMed ID: 10653059
[TBL] [Abstract][Full Text] [Related]
12. Cardiac pacemakers and implantable defibrillators in terminal care.
Braun TC; Hagen NA; Hatfield RE; Wyse DG
J Pain Symptom Manage; 1999 Aug; 18(2):126-31. PubMed ID: 10484860
[TBL] [Abstract][Full Text] [Related]
13. The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.
Carlsson J; Paul NW; Dann M; Neuzner J; Pfeiffer D
Dtsch Arztebl Int; 2012 Aug; 109(33-34):535-41. PubMed ID: 23152737
[TBL] [Abstract][Full Text] [Related]
14. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.
England R; England T; Coggon J
J Med Ethics; 2007 Sep; 33(9):538-40. PubMed ID: 17761824
[TBL] [Abstract][Full Text] [Related]
15. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
Pilkington BC
J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
[TBL] [Abstract][Full Text] [Related]
16. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
17. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
Zellner RA; Aulisio MP; Lewis WR
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
[No Abstract] [Full Text] [Related]
18. Deactivating implantable cardioverter defibrillators.
Lynn J
Ann Intern Med; 2005 Nov; 143(9):691; author reply 691. PubMed ID: 16263897
[No Abstract] [Full Text] [Related]
19. Withdrawing implantable defibrillator shock therapy in terminally ill patients.
Lewis WR; Luebke DL; Johnson NJ; Harrington MD; Costantini O; Aulisio MP
Am J Med; 2006 Oct; 119(10):892-6. PubMed ID: 17000222
[TBL] [Abstract][Full Text] [Related]
20. [Postmortem explantation of an implantable defibrillator or pacemaker].
Bosch B; Maass AH
Ned Tijdschr Geneeskd; 2010; 154():A1840. PubMed ID: 20719015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
